Emerald Resources NL (ASX:EMR) has applied for quotation of 88,298 fully paid ordinary shares on the ASX, following the exercise of two tranches of options on 16 November 2026, bringing total quoted ordinary shares on issue to 663,557,900.
Key Points
- A total of 88,298 ordinary fully paid shares are to be quoted, with an issue date of 16 November 2026.
- 60,000 options under code EMRAN (expiring 17 October 2027, exercise price A$1.37) were exercised for cash consideration at A$1.37 per security.
- 50,000 options under code EMRAQ (expiring 12 September 2028, exercise price A$2.84) were exercised, with 28,298 shares to be quoted after the holder used the cashless exercise facility under the company's Incentive Plan.
- The EMRAQ options exercised were held by key management personnel (KMP) or an associate, and were issued under an employee incentive scheme.
- Following quotation, total quoted ordinary shares on issue will be 663,557,900.
Option Exercise Details — EMRAN Tranche
According to the filing, 60,000 options under ASX security code EMRAN, with an expiry date of 17 October 2027 and an exercise price of A$1.37, were exercised on 16 November 2026. These options converted into 60,000 ordinary fully paid shares. The securities were issued for cash consideration in Australian dollars at A$1.37 per security. The filing states the new shares will rank equally in all respects from their issue date with existing issued securities in the same class. The options were not confirmed as all of that type on issue.
Option Exercise Details — EMRAQ Tranche and Cashless Facility
The filing discloses that 50,000 options under ASX security code EMRAQ, expiring 12 September 2028 with an exercise price of A$2.84, were also exercised on 16 November 2026. The holder elected to pay the option price using the cashless exercise facility provided under the company's Incentive Plan, resulting in 28,298 ordinary fully paid shares being quoted. The filing states an estimated consideration value of A$6.54 per security. These options were issued under an employee incentive scheme and were held by key management personnel or an associate.
Issued Capital Following Quotation
Following the quotation of the 88,298 securities, the total number of quoted ordinary fully paid shares on issue in the EMR class will be 663,557,900, according to the filing. The company also holds a range of unquoted option series on issue, including EMRAN with 920,000 options remaining, EMRAQ with 1,680,000 options remaining, and additional series with expiry dates ranging through to 2031. The new shares rank equally in all respects with existing issued securities in the ordinary fully paid class from their issue date of 16 November 2026.



Please wait processing your request...